10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2016 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 27, 2017) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Revenues | |||
| Product sales | $ 29,953 | 32,151 | 24,474 |
| Royalty, contract and other revenues | 437 | 488 | 416 |
| Total revenues | 30,390 | 32,639 | 24,890 |
| Costs and Expenses | |||
| Cost of goods sold | 4,261 | 4,006 | 3,788 |
| Research and development expenses | 5,098 | 3,014 | 2,854 |
| Selling, general and administrative expenses | 3,398 | 3,426 | 2,983 |
| Total costs and expenses | 12,757 | 10,446 | 9,625 |
| Income from operations | 17,633 | 22,193 | 15,265 |
| Interest expense | (964) | (688) | (412) |
| Other income (expense), net | 428 | 154 | 3 |
| Income before provision for income taxes | 17,097 | 21,659 | 14,856 |
| Provision for income taxes | 3,609 | 3,553 | 2,797 |
| Net income | 13,488 | 18,106 | 12,059 |
| Net loss attributable to noncontrolling interest | (13) | (2) | (42) |
| Net income attributable to Gilead | 13,501 | 18,108 | 12,101 |
| Net income per share attributable to Gilead common stockholders - basic | 10.08 | 12.37 | 7.95 |
| Shares used in per share calculation - basic | 1,339 | 1,464 | 1,522 |
| Net income per share attributable to Gilead common stockholders - diluted | 9.94 | 11.91 | 7.35 |
| Shares used in per share calculation - diluted | 1,358 | 1,521 | 1,647 |
| Cash dividends declared per share | 1.84 | 1.29 | 0.00 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |